a 2023

Exploring patterns in clinical, biological, and molecular data of leukemia patients with CLLue.

REIGL, Tomáš, Veronika NAVRKALOVÁ, Jakub Paweł PORC, Karol PÁL, Kamila STRÁNSKÁ et. al.

Basic information

Original name

Exploring patterns in clinical, biological, and molecular data of leukemia patients with CLLue.

Authors

REIGL, Tomáš, Veronika NAVRKALOVÁ, Jakub Paweł PORC, Karol PÁL, Kamila STRÁNSKÁ, Šárka POSPÍŠILOVÁ and Karla PLEVOVÁ

Edition

CEITEC PhD Conference, 2023

Other information

Language

English

Type of outcome

Konferenční abstrakta

Country of publisher

Czech Republic

Confidentiality degree

is not subject to a state or trade secret

References:

Organization

Středoevropský technologický institut – Repository – Repository

Keywords in English

leukemia; LYmphoid NeXt-Generation Sequencing; LYNX;

Links

LM2018140, research and development project. LX22NPO5102, research and development project. NU21-08-00237, research and development project. NU22-08-00227, research and development project.
Changed: 25/3/2024 03:21, RNDr. Daniel Jakubík

Abstract

V originále

High throughput sequencing data analysis of IG/TR rearranged genes in leukemia clinical research', he has been involved in the development of several software projects, e.g.: LYNX (LYmphoid NeXt-Generation Sequencing) analytical software, CLLue, ARResT/Interrogate, ARResT/Subsets aka Encyclopedia of CLL Subsets. LYNX is a tailor-made bioinformatic tool for a new custom-designed capture-based NGS panel. With this tool, a user can analyze molecular markers, such as gene mutations, copy number variations, antigen receptor rearrangements, and translocations in the most common lymphoid malignancies. CLLue is an interactive web-based tool that allows users to perform a visual exploratory data analysis, identification of important and significant features in given groups based on statistical tests, and de novo clustering on their data.

Files attached